| [1] |
Zheng JJ, Zhao Y, Wang YF, et al. The infrared radiation temperature characteristic of acupoints of mammary gland hyperplasia patients[J]. Evid Based Complement Alternat Med, 2013, 2013: 567987. doi:10.1155/2013/567987
|
| [2] |
Yang XJ, Pei XH. Review of mammary gland hyperplasia in classical Chinese medical literature[J]. Altern Ther Health Med, 2023, 29(6): 97-105.
|
| [3] |
Blundell S, Deshmukh M, McGregor A. A painful breast mass[J]. Clin Infect Dis, 2022, 75(12): 2275-7. doi:10.1093/cid/ciac250
|
| [4] |
Sun LL, Sun HJ, Wang JQ, et al. Breast mass detection in mammography based on image template matching and CNN[J]. Sensors, 2021, 21(8): 2855. doi:10.3390/s21082855
|
| [5] |
Chen T, Li JJ, Chen JL, et al. Anti-hyperplasia effects of Rosa rugosa polyphenols in rats with hyperplasia of mammary gland[J]. Environ Toxicol Pharmacol, 2015, 39(2): 990-6. doi:10.1016/j.etap.2015.02.014
|
| [6] |
Ping Y, Gao Q, Li CX, et al. Construction of microneedle of Atractylodes macrocephala Rhizoma aqueous extract and effect on mammary gland hyperplasia based on intestinal flora[J]. Front Endocrinol, 2023, 14: 1158318. doi:10.3389/fendo.2023.1158318
|
| [7] |
Arthur R, Wang YH, Ye K, et al. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease[J]. Breast Cancer Res Treat, 2017, 165(3): 623-31. doi:10.1007/s10549-017-4347-9
|
| [8] |
Zhang H, Zhang ZY, Li WH, et al. Clinical efficacy of “Sancai therapy” for hyperplasia of the mammary glands: a systematic review and meta-analysis[J]. Medicine, 2023, 102(45): e35989. doi:10.1097/md.0000000000035989
|
| [9] |
Lin N, Qiu YW, He GY, et al. Effects of Litchi chinensis seed saponins on inhibiting hyperplasia of mammary glands and influence on signaling pathway of estrogen in rats[J]. Zhongyaocai, 2015, 38(4): 798-802.
|
| [10] |
Bhatti SFM, Rao NAS, Okkens AC, et al. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch[J]. Domest Anim Endocrinol, 2007, 33(3): 294-312. doi:10.1016/j.domaniend.2006.06.005
|
| [11] |
Wibowo E, Pollock PA, Hollis N, et al. Tamoxifen in men: a review of adverse events[J]. Andrology, 2016, 4(5): 776-88. doi:10.1111/andr.12197
|
| [12] |
Zhou JJ, Zhang Y, Chang KT, et al. Diagnosis of benign and malignant breast lesions on DCE-MRI by using radiomics and deep learning with consideration of peritumor tissue[J]. J Magn Reson Imaging, 2020, 51(3): 798-809. doi:10.1002/jmri.26981
|
| [13] |
Li XL, Xin P, Wang CF, et al. Mechanisms of traditional Chinese medicine in the treatment of mammary gland hyperplasia[J]. Am J Chin Med, 2017, 45(3): 443-58. doi:10.1142/s0192415x17500276
|
| [14] |
Xiong J, Li HL, Hua FH, et al. Acupuncture for mammary gland hyperplasia: a Bayesian network meta-analysis protocol[J]. Medicine, 2020, 99(36): e22055. doi:10.1097/md.0000000000022055
|
| [15] |
Li DD, Wang C, Ruan D, et al. Chinese massage, Tui Na, combined with herbs improves clinical symptoms and regulates sex hormones in patients with mammary gland hyperplasia[J]. Medicine, 2020, 99(21): e20300. doi:10.1097/md.0000000000020300
|
| [16] |
Gao ZQ, Mi R, Cheng ZX, et al. Integrated metabolomics and network pharmacology revealed Hong-Hua-Xiao-Yao Tablet's effect of mediating hormone synthesis in the treatment of mammary gland hyperplasia[J]. Front Pharmacol, 2022, 13: 788019. doi:10.3389/fphar.2022.788019
|
| [17] |
Mustafa M, Ahmad R, Tantry IQ, et al. Apoptosis: a comprehensive overview of signaling pathways, morphological changes, and physiological significance and therapeutic implications[J]. Cells, 2024, 13(22): 1838. doi:10.3390/cells13221838
|
| [18] |
Liu J, Zhang JF, Gong GH, et al. Therapeutic effect of Mongolian medicine RuXian-I on hyperplasia of mammary gland induced by estrogen/progesterone through CRYAB-promoted apoptosis[J]. Evid Based Complement Alternat Med, 2020, 2020: 5707106. doi:10.1155/2020/5707106
|
| [19] |
Alfaro-Murillo A, Correa-Jimenez O, González-Chapa J, et al. Late-onset autoimmune lymphoproliferative syndrome in a costa Rican woman[J]. Cureus, 2023, 15(12): e50226.
|
| [20] |
Huang FB, Ruan YC, He XJ, et al. Correction: Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review[J]. World J Surg Oncol, 2023, 21(1): 382. doi:10.1186/s12957-023-03259-4
|
| [21] |
Li XL, Wang ZB, Wang Y, et al. Anti-hyperplasia effects of total saponins from phytolaccae Radix in rats with mammary gland hyperplasia via inhibition of proliferation and induction of apoptosis[J]. Front Pharmacol, 2018, 9: 467. doi:10.3389/fphar.2018.00467
|
| [22] |
Kaloni D, Diepstraten ST, Strasser A, et al. BCL-2 protein family: attractive targets for cancer therapy[J]. Apoptosis, 2023, 28(1/2): 20-38. doi:10.1007/s10495-022-01780-7
|
| [23] |
Tian XB, Srinivasan PR, Tajiknia V, et al. Targeting apoptotic pathways for cancer therapy[J]. J Clin Invest, 2024, 134(14): e179570. doi:10.1172/jci179570
|
| [24] |
Liang CL, Mu XL, Bao QL, et al. Exploring the inhibitory impact of Mongolian medicinal He-Zi-3 soup on mammary gland hyperplasia in rats induced by estrogen and progestogen[J]. J Ethnopharmacol, 2024, 329: 117854. doi:10.1016/j.jep.2024.117854
|
| [25] |
Budas GR, Boehm M, Kojonazarov B, et al. ASK1 inhibition halts disease progression in preclinical models of pulmonary arterial hypertension[J]. Am J Respir Crit Care Med, 2018, 197(3): 373-85. doi:10.1164/rccm.201703-0502oc
|
| [26] |
Yuan ML, Zhang Y, Wang L, et al. Study on the mechanism of Tong-Qiao-Huo-Xue decoction regulating apoptosis via ASK1/MKK4/JNK pathway in MCAO/R rats[J]. Phytomedicine, 2022, 106: 154437. doi:10.1016/j.phymed.2022.154437
|
| [27] |
易维真, 张 珺, 周 导, 等. 消核冲剂对乳腺增生大鼠性激素水平及PCNA表达的影响[J]. 安徽中医学院学报, 2008, 27(3): 32-5. doi:10.3969/j.issn.1000-2219.2008.03.015
|
| [28] |
徐英纳, 易维真, 张福忠. 消核冲剂对乳腺增生病大鼠治疗作用的观察[J]. 中医药临床杂志, 2006, 18(1): 37-9. doi:10.3969/j.issn.1672-7134.2006.01.023
|
| [29] |
姚玲莉, 王金秋, 叶 丹, 等. 夏枯草颗粒对乳腺增生模型大鼠增生乳腺组织Bcl-2、Bax、PCNA蛋白表达的影响[J]. 浙江中西医结合杂志, 2022, 32(2): 104-9. doi:10.3969/j.issn.1005-4561.2022.02.003
|
| [30] |
Amos LA, Ma FY, Tesch GH, et al. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis[J]. J Cell Mol Med, 2018, 22(9): 4522-33. doi:10.1111/jcmm.13705
|
| [31] |
Liles JT, Corkey BK, Notte GT, et al. ASK1 contributes to fibrosis and dysfunction in models of kidney disease. J Clin Invest. 2018;128(10):4485-4500. doi:10.1172/jci99768
|
| [32] |
Newton K, Strasser A, Kayagaki N, et al. Cell death[J]. Cell, 2024, 187(2): 235-56. doi:10.1016/j.cell.2023.11.044
|
| [33] |
Yuan JY, Ofengeim D. A guide to cell death pathways[J]. Nat Rev Mol Cell Biol, 2024, 25(5): 379-95. doi:10.1038/s41580-023-00689-6
|
| [34] |
Morgan MM, Livingston MK, Warrick JW, et al. Mammary fibroblasts reduce apoptosis and speed estrogen-induced hyperplasia in an organotypic MCF7-derived duct model[J]. Sci Rep, 2018, 8(1): 7139. doi:10.1038/s41598-018-25461-1
|
| [35] |
Li JM, Zhang Y, Peng D, et al. Integrating UPLC-Q-TOF-MS, network pharmacology, molecular docking, and molecular dynamics simulation to reveal the material basis and mechanism of Xiangshao Sanjie oral liquid in treating hyperplasia of mammary glands[J]. J Pharm Biomed Anal, 2025, 266: 117074. doi:10.1016/j.jpba.2025.117074
|
| [36] |
Yang F, Li MZ, Xu D, et al. Inhibition of JNK/c-Jun-ATF2 overcomes cisplatin resistance in liver cancer through down-regulating galectin-1[J]. Int J Biol Sci, 2023, 19(8): 2366-81. doi:10.7150/ijbs.79163
|
| [37] |
Xiao JJ, Lu H, Ma TF, et al. Worenine prevents solar ultraviolet-induced sunburn by inhibiting JNK2[J]. Front Pharmacol, 2022, 13: 881042. doi:10.3389/fphar.2022.881042
|
| [38] |
Xiao JJ, Liu Q, Li Y, et al. Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway[J]. Cell Death Dis, 2022, 13(9): 774. doi:10.1038/s41419-022-05220-x
|
| [39] |
Kumari S, Dhapola R, Reddy DH. Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenues[J]. Apoptosis, 2023, 28(7/8): 943-57. doi:10.1007/s10495-023-01848-y
|
| [40] |
Chu C, Ru H, Chen YY, et al. Gallic acid attenuates LPS-induced inflammation in Caco-2 cells by suppressing the activation of the NF-κB/MAPK signaling pathway[J]. Acta Biochim Biophys Sin, 2024, 56(6): 905-15.
|
| [41] |
Sun JT, Wang XD, Xu T, et al. Quercetin antagonizes apoptosis, autophagy and immune dysfunction induced by di(2-ethylhexyl) phthalate via ROS/ASK1/JNK pathway[J]. Comp Biochem Physiol C Toxicol Pharmacol, 2024, 285: 109991. doi:10.1016/j.cbpc.2024.109991
|
| [42] |
Fan MZ, Miao YY, Yan YT, et al. C-type natriuretic peptide regulates the expression and secretion of antibacterial peptide S100A7 in goat mammary gland through PKG/JNK/c-Jun signaling pathway[J]. Front Vet Sci, 2022, 9: 822165. doi:10.3389/fvets.2022.822165
|
| [43] |
Kim KW, Im J, Jeon JH, et al. Staphylococcus aureus induces IL-1β expression through the activation of MAP kinases and AP-1, CRE and NF‑κB transcription factors in the bovine mammary gland epithelial cells[J]. Comp Immunol Microbiol Infect Dis, 2011, 34(4): 347-54. doi:10.1016/j.cimid.2011.04.004
|
| [44] |
Liu YF, An T, Yu H, et al. Xiaozheng pill exerts an anti-mammary hyperplasia effect through Raf/ERK/ELK and HIF-1α/bFGF pathways[J]. J Tradit Complement Med, 2023, 13(6): 600-10. doi:10.1016/j.jtcme.2023.05.002
|
| [45] |
Le TKC, Dao XD, Nguyen DV, et al. Insulin signaling and its application[J]. Front Endocrinol, 2023, 14: 1226655. doi:10.3389/fendo.2023.1226655
|
| [46] |
Yu JF, Li S, Chen DZ, et al. SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal[J]. J Hematol Oncol, 2022, 15(1): 167. doi:10.1186/s13045-022-01385-2
|
| [47] |
Guo PF, Wan SC, Guan KL. The Hippo pathway: Organ size control and beyond[J]. Pharmacol Rev, 2025, 77(2): 100031. doi:10.1016/j.pharmr.2024.100031
|
| [48] |
Wang B, Ma Y, Zhang Y, et al. Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions[J]. Biomed Pharmacother, 2024, 178: 117214. doi:10.1016/j.biopha.2024.117214
|
| [49] |
Tsuchiya A, Kaku Y, Nakano T, et al. Diarachidonoyl-phosphoethanolamine induces apoptosis of malignant pleural mesothelioma cells through a Trx/ASK1/p38 MAPK pathway[J]. J Pharmacol Sci, 2015, 129(3): 160-8. doi:10.1016/j.jphs.2015.10.003
|
| [50] |
Ashraf U, Ding Z, Deng SZ, et al. Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage[J]. Virulence, 2021, 12(1): 968-80. doi:10.1080/21505594.2021.1899674
|
| [51] |
Feng H, Cao JL, Zhang GY, et al. Kaempferol attenuates cardiac hypertrophy via regulation of ASK1/MAPK signaling pathway and oxidative stress[J]. Planta Med, 2017, 83(10): 837-45. doi:10.1055/s-0043-103415
|